Genetic basis for dissemination of armA

Bruno González-Zorn*, Ana Catalan{dagger}, Jose A. Escudero{dagger}, Lucas Domínguez, Tirushet Teshager, Concepción Porrero and Miguel Angel Moreno

Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid, Spain


* Corresponding author. Tel: +34-91-3943719; Fax: +34-91-3943908; E-mail: bgzorn{at}vet.ucm.es

Received 11 May 2005; returned 19 May 2005; revised 26 May 2005; accepted 15 June 2005


    Abstract
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Objectives and methods: armA is a novel plasmid-borne 16S rRNA methyltransferase that confers high-level resistance to 4,6-disubstituted deoxystreptamines. Recently, we have isolated from a high-level broad-spectrum aminoglycoside-resistant Escherichia coli animal isolate a plasmid, pMUR050, that bore the armA gene. In order to elucidate the genetic basis for the spread of armA, we have determined the complete nucleotide sequence of pMUR050.

Results: armA was borne by a complex transposon composite flanked by two direct repeats of IS26. The transposon composite included a class one integron with sul1 for resistance to sulphonamides and ant3''9 conferring resistance to spectinomycin–streptomycin, and a macrolide efflux pump and mefE/mel conferring high-level resistance to erythromycin. We identified in GenBank that another plasmid, pCTX-M3, from a Polish Citrobacter freundii human isolate, bore the same genetic structure, including armA.

Conclusions: armA is present in human and animal isolates within a novel transposon composite. Further spread of armA between bacteria of diverse origin is to be expected.

Keywords: Escherichia coli , animal isolates , 16S rRNA methylase , aminoglycoside resistance , IncN , transposon composite


    Introduction
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Aminoglycosides are currently used for the treatment of a broad range of life-threatening infections due to both Gram-positive and Gram-negative bacteria.1 Until recently, resistance to these antibiotics in pathogenic bacteria was restricted to production of aminoglycoside-modifying enzymes, decrease in intracellular antibiotic accumulation and mutation of ribosomal proteins or rRNA.2 A new type of mechanism, methylation of 16S rRNA, conferred by a single gene, armA, has recently been described in a human Klebsiella pneumoniae isolate.3 We have identified armA in an Escherichia coli animal isolate, MUR050.4 This gene conferred high-level resistance to 4,6-substituted deoxystreptamines, including arbekacin, amikacin, kanamycin, tobramycin and gentamicin, and could be transferred to other E. coli by conjugation. Resistance was due to the presence of a single gene, armA, encoding a protein similar to 16S rRNA methylases found in aminoglycoside-producing actinomycetes. The armA gene has also been detected by PCR in additional Enterobacteriaceae from separate hospitals throughout Europe and Japan, showing that high-level aminoglycoside resistance due to armA in Enterobacteriaceae is not a specific finding, but rather a widespread phenomenon that represents a serious clinical challenge.5 Interestingly, in our E. coli animal isolate, armA was borne by a plasmid, pMUR050, belonging to the IncN incompatibility group, in contrast to human isolates, in which armA has been located in IncL/M plasmids. In this study, we investigated the genetic environment of the armA gene in pMUR050 and show that armA is embedded in a novel transposon composite, making spread between Enterobacteriaceae of human and animal origin likely.


    Materials and methods
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Bacterial strains

The clinical strain E. coli MUR050 was isolated from a diarrhoeic pig in 2002. The laboratory strains E. coli INV{alpha}F' [F– mcrA (mrr-hsdRMS-mcrBC) 80lacZM15 lacX74 recA1 ara139 (ara-leu)7697 galU galK rpsL (StrR) endA1 nupG] and DH5{alpha} [endA1, gyrA96, hsdR17(rk mk+), recA1, relA1, supE44, thi-1, D(lacZYA-argF) U169, f80dl acZDM15, F, lPN25/tetR, Placi q/laci, Spr] were used for cloning purposes and transformed following the manufacturer's instructions (Invitrogen, Carlsbad, CA, USA).

Susceptibility tests

Bacteria were tested using the Etest (AB Biodisk, Solna, Sweden), and interpretation of susceptibility test results was conducted following the recommendations of the manufacturer. For neomycin and apramycin (Izasa, Madrid, Spain), the MICs were determined by microdilution as previously described.6

DNA sequencing and analysis of pMUR050

Plasmid DNA was extracted from the strain, and re-extracted from an agarose gel to avoid contamination with genomic DNA.7 The purified plasmid DNA (Qiagen, Inc., Chatworth, CA, USA) was digested with Sau3A (Sigma, St Louis, MO, USA) and the resulting fragments ligated with plasmid pBluescript KS+ DNA (Stratagene, La Jolla, CA, USA). The ligation mixture was transformed into E. coli DH5{alpha} and plated on agar containing ampicillin (50 mg/L). The inserts of plasmids from 288 random clones, corresponding to approximately three times the estimated size of pMUR050 (50 kbp) giving a mean cloned fragment of 500 bp, were sequenced in both strands with standard oligonucleotides using an ABI Prism DNA Sequencer apparatus (Perkin-Elmer, Foster City, CA, USA). The DNA sequences were assembled using DNASTAR (Madison, WI, USA).


    Results
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Resistance conferred by pMUR050 and sequence analysis

pMUR050 was transformed into the laboratory strain E. coli INV{alpha}F', in which it conferred high-level resistance to 4,6-disubstituted aminoglycosides. This strain was also resistant to other aminoglycosides, sulphonamides and macrolides, showing that resistance determinants other than armA were encoded in pMUR050 (Table 1).


View this table:
[in this window]
[in a new window]
 
Table 1. Antibiotic resistance conferred by pMUR050

 
To determine the genetic basis of this phenomenon, we determined the complete nucleotide sequence of pMUR050 locus by shotgun sequencing. The plasmid has a size of 56 637 bp. Nucleotide sequences were analysed using BLAST.8 One set of fragments was 99% identical with the conjugative plasmid R46 of the IncN incompatibility group from Salmonella typhimurium.9 All genes involved in plasmid replication, mobilization and conjugation, such as repA, oriT and the tra family were identified (data not shown), confirming that an R46-like replicon was the carrier of armA. A continuous DNA fragment (GenBank accession number AY522432) with a size of 18 kbp contained all antimicrobial-resistant genes encoded in pMUR050. This fragment included armA and two further genes coding for resistance to aminoglycosides: ant3''9 and aph3'-I, explaining the broad-spectrum high-level aminoglycoside resistance conferred by pMUR050. sul1, conferring resistance to sulphonamides, the genes coding for the macrolide resistance efflux-pump mefE/mel, characteristic of streptococci,10 linF and a macrolide phosphotransferase gene, mph, were also identified in the fragment.

armA is located in a complex transposon composite

The structural gene for ArmA was preceded by a putative transposase gene, tnpU, followed by a class one integron formed by intI1-ant3''9-qacE{Delta}1-sul1-orf513. Downstream of armA, the genes coding for another transposase, tnpD, a mefE/mel macrolide efflux pump and a macrolide phosphotransferase gene, mph, were located. All these genes, the armA locus, were flanked by two copies of IS26. IS26 belongs to the IS6 family of insertion sequences. This family is characterized by the fact that it gives rise exclusively to replicon fusions (cointegrates) in which the donor and target replicons are separated by two directly repeated IS copies. Upon cointegration, mediated by either of the two IS26 elements, the IS element is duplicated in a direct repeat.11 The two IS26 elements at both ends of armA are in direct repeat, forming a putative mobile transposon composite of 15 kbp.

armA transposon composite in other bacterial species

In order to elucidate if this putative mobile genetic element was responsible for the spread of armA, the databases were checked for similar genetic structures. Interestingly, a conjugative plasmid isolated in a Polish hospital from Citrobacter freundii, pCTX-M3, bore the same transposon composite, including armA, with an additional dhfrXII gene and orfF upstream of ant3''9 (Figure 1). Furthermore, the two additional isolates in which armA has been identified to date, a K. pneumoniae in France3 and an E. coli in Japan (GenBank accession number AB117519), are hospital isolates that showed the same genetic organization flanking the armA gene (Figure 1). Overall, our results show that armA has spread within a unique transposon composite both by transposition and conjugation, between different species of Enterobacteriaceae involving animal and human isolates.



View larger version (13K):
[in this window]
[in a new window]
 
Figure 1. Comparison of the genetic organization of the armA environments in bacteria of different origins. ORFs connected by yellow shading represent ≥99% nucleotide identity. Black boxes are IS26. Red and orange represent resistance to aminoglycosides, and dark blue represents resistance to macrolides. GenBank accession numbers are from above: AY522431, NC004464, AY220558 and AB117519.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Other authors have recently described two novel 16S rRNA methylases that also confer high-level aminoglycoside resistance in Japanese isolates of Pseudomonas aeruginosa and Serratia marcescens.12,13 The genes coding for these methylases, rmtA and rmtB, could also be transferred to other bacteria by conjugation or transformation, indicating that, like armA, rmtA and rmtB can be part of conjugative plasmids. Recently, the description of the genetic environment of rmtA in clinical isolates of P. aeruginosa has given insight into the spread of this methylase within Japan.14 In the French K. pneumoniae isolate, armA has been located on a mobilizable transposon Tn1548.15 Thus, armA is already spread by a novel transposon composite in Europe and Japan, and it is likely that it will soon be detected in other regions worldwide.

E. coli MUR050 was isolated from a diarrhoeic pig in south-east Spain.4 The fact that this strain bore armA was already striking, because this gene had only been described in a few human isolates worldwide. In this study, we have further demonstrated that the genetic background for the spread of armA is the same in human and animal strains, indicating that the armA transposon composite will be further detected in Enterobacteriaceae of very diverse origins. This is specially worrisome, as the extended use of sulphonamides or macrolides would select for the presence of the transposon composite, including armA, ant3''9, the melF-mef and mph genes. Extended surveillance of both human and animal isolates should be reinforced, if resistance to aminoglycosides is to be delayed.


    Footnotes
 
{dagger} These authors contributed equally to this work. Back


    Acknowledgements
 
This work was supported in part by grant AGL2002/02637.


    References
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
1. Mingeot-Leclercq MP, Glupczynski Y, Tulkens PM. Aminoglycosides: activity and resistance. Antimicrob Agents Chemother 1999; 43: 727–37.[Free Full Text]

2. Davies J, Wright GD. Bacterial resistance to aminoglycoside antibiotics. Trends Microbiol 1997; 5: 234–40.[CrossRef][ISI][Medline]

3. Galimand M, Courvalin P, Lambert T. Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation. Antimicrob Agents Chemother 2003; 47: 2565–71.[Abstract/Free Full Text]

4. González-Zorn B, Teshager T, Casas M et al. armA and aminoglycoside resistance in Escherichia coli. Emerg Infect Dis 2005; 11: 954–6.[ISI][Medline]

5. Galimand M, Sabtcheva S, Kantardjiev T et al. The armA aminoglycoside resistance methylase gene is disseminated in Enterobacteriaceae by an IncL/M plasmid mediating CTX-M3 ß-lactamase. In: Programs and Abstracts of the Forty-third Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 2003. Abstract C2-59, p. 111. American Society for Microbiology, Washington, DC, USA.

6. Teshager T, Herrero IA, Porrero MC et al. Surveillance of antimicrobial resistance in Escherichia coli strains isolated from pigs at Spanish slaughterhouses. Int J Antimicrob Agents 2000; 15: 137–42.[CrossRef][ISI][Medline]

7. Ausubel FM, Brent R, Kingston RE et al. Current Protocols in Molecular Biology. New York: John Wiley & Sons, 1987.

8. Altschul SF, Gish W, Miller W et al. Basic local alignment search tool. J Mol Biol 1990; 215: 403–10.[CrossRef][ISI][Medline]

9. Brown AMC, Willetts NSA. Physical and genetic map of the IncN plasmid R46. Plasmid 1981; 5: 188–201.[CrossRef][ISI][Medline]

10. Gay K, Stephens DS. Structure and dissemination of a chromosomal insertion element encoding macrolide efflux in Streptococcus pneumoniae. J Infect Dis 2001; 184: 56–65.[CrossRef][ISI][Medline]

11. Iida S, Mollet B, Meyer J et al. Functional characterization of the prokaryotic mobile genetic element IS26. Mol Gen Genet 1984; 198: 84–9.[CrossRef][ISI][Medline]

12. Yokoyama K, Doi Y, Yamane K et al. Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa. Lancet 2003; 362: 1888–93.[CrossRef][ISI][Medline]

13. Doi Y, Yokoyama K, Yamane K et al. Plasmid-mediated 16S rRNA methylase in Serratia marcescens conferring high-level resistance to aminoglycosides. Antimicrob Agents Chemother 2004; 48: 491–6.[Abstract/Free Full Text]

14. Yamane K, Doi Y, Yokoyama K et al. Genetic environments of the rmtA gene in Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 2004; 48: 2069–74.[Abstract/Free Full Text]

15. Lambert T, Galimand M, Sabtcheva S et al. The armA aminoglycoside resistance methylase gene is borne by composite transposon Tn1548. In: Programs and Abstracts of the Forty-fourth Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 2004. Abstract C1-1496, p. 85. American Society for Microbiology, Washington, DC, USA.





This Article
Abstract
Full Text (PDF)
All Versions of this Article:
56/3/583    most recent
dki246v1
Alert me when this article is cited
Alert me if a correction is posted
Services
Email this article to a friend
Similar articles in this journal
Similar articles in ISI Web of Science
Similar articles in PubMed
Alert me to new issues of the journal
Add to My Personal Archive
Download to citation manager
Search for citing articles in:
ISI Web of Science (1)
Disclaimer
Request Permissions
Google Scholar
Articles by González-Zorn, B.
Articles by Moreno, M. A.
PubMed
PubMed Citation
Articles by González-Zorn, B.
Articles by Moreno, M. A.